cedars-sinai.org
Nov 13, 2024, 23:54
The Lung-MAP 3.0 revision
“The Lung-MAP 3.0 revision:
- has a simpler, pragmatic screening process
- uses results of patients’ previous tests
- removes the need for dedicated pre-screening
- is a response to requests from clinical sites.”
More posts featuring Lung-MAP.
Dr. Karen Reckamp is a Professor of Medicine and the Director of the Division of Medical Oncology at Cedars-Sinai Medical Center. Her research focuses on developing novel therapies and biomarkers for lung cancer, particularly targeted therapies.
Dr. Reckamp is an active member of the Southwest Oncology Group (SWOG) and its Lung Cancer Committee. She also represented City of Hope on the National Comprehensive Cancer Network Guidelines Committee, shaping treatment guidelines for thoracic malignancies from 2008 to 2020.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Sep 2, 2025, 08:02
Sep 2, 2025, 07:38
Sep 2, 2025, 07:03